NCT04004507View on ClinicalTrials.gov

Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

February 29, 2008

Conditions
Decrease in Night VisionDisturbance; Vision, Loss
Interventions
DRUG

Phentolamine Mesylate Ophthalmic Solution 1%

Topical Sterile Ophthalmic Solution

OTHER

Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)

Topical Sterile Ophthalmic Solution

Trial Locations (1)

11563

Ophthalmic Consultants of Long Island, NY, Lynbrook

Sponsors
All Listed Sponsors
collaborator

Ophthalmic Consultants of Long Island

OTHER

lead

Ocuphire Pharma, Inc.

INDUSTRY

NCT04004507 - Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances | Biotech Hunter | Biotech Hunter